Oral anticoagulant anticoagulant warfarin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Diseases18

Thromboembolism Hemorrhage Thrombophlebitis Atrial Fibrillation Venous Thromboembolism Thrombosis Venous Thrombosis Pulmonary Embolism Stroke Thrombophilia Blood Coagulation Disorders Embolism Hematoma Antiphospholipid Syndrome Postoperative Hemorrhage Intracranial Hemorrhages Cerebral Hemorrhage Recurrence

Chemicals and Drugs47

Warfarin Anticoagulants Acenocoumarol beta-Alanine Phenindione Vitamin K Phenprocoumon Lupus Coagulation Inhibitor Vitamin K Epoxide Reductases Antithrombins Factor Xa Thiophenes Pyridones Protein C Heparin Benzimidazoles Heparin, Low-Molecular-Weight Rodenticides Prothrombin Blood Coagulation Factors 4-Hydroxycoumarins Aspirin Platelet Aggregation Inhibitors Morpholines Fibrinolytic Agents Thrombin Protein S Factor X Dicumarol Coumarins Thrombomodulin Enoxaparin Thromboplastin Coagulants Mixed Function Oxygenases Antibodies, Antiphospholipid Antithrombin III Azetidines Factor VII Pyrazoles Antibodies, Anticardiolipin Aryl Hydrocarbon Hydroxylases Fibrin Fibrinogen Degradation Products Heparin Antagonists Hirudins Factor V beta 2-Glycoprotein I

Analytical, Diagnostic and Therapeutic Techniques and Equipment18

Prothrombin Time International Normalized Ratio Administration, Oral Blood Coagulation Tests Partial Thromboplastin Time Drug Monitoring Thrombin Time Treatment Outcome Oral Surgical Procedures Heart Valve Prosthesis Perioperative Care Risk Factors Randomized Controlled Trials as Topic Prospective Studies Drug Substitution Follow-Up Studies Pharmacovigilance Drug Therapy, Combination

Phenomena and Processes8

Prothrombin Time Blood Coagulation Partial Thromboplastin Time Thrombin Time Hemostasis Drug Interactions Time Factors Dose-Response Relationship, Drug

Disciplines and Occupations1

Pharmacogenetics

Information Science1

Pharmacovigilance

Health Care9

Treatment Outcome Perioperative Care Risk Factors Rodent Control Randomized Controlled Trials as Topic Prospective Studies Drug Substitution Follow-Up Studies Pharmacovigilance

Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Warfarin Anticoagulants Acenocoumarol beta-Alanine Prothrombin Time International Normalized Ratio Thromboembolism Administration, Oral Hemorrhage Phenindione Vitamin K Phenprocoumon Blood Coagulation Lupus Coagulation Inhibitor Vitamin K Epoxide Reductases Antithrombins Thrombophlebitis Factor Xa Blood Coagulation Tests Atrial Fibrillation Thiophenes Partial Thromboplastin Time Pyridones Protein C Heparin Benzimidazoles Heparin, Low-Molecular-Weight Venous Thromboembolism Rodenticides Thrombosis Prothrombin Blood Coagulation Factors Venous Thrombosis Drug Monitoring 4-Hydroxycoumarins Pulmonary Embolism Aspirin Platelet Aggregation Inhibitors Thrombin Time Morpholines Stroke Thrombophilia Blood Coagulation Disorders Fibrinolytic Agents Thrombin Protein S Factor X Dicumarol Coumarins Thrombomodulin Enoxaparin Thromboplastin Coagulants Embolism Treatment Outcome Hematoma Antiphospholipid Syndrome Mixed Function Oxygenases Pharmacogenetics Oral Surgical Procedures Postoperative Hemorrhage Hemostasis Antibodies, Antiphospholipid Drug Interactions Heart Valve Prosthesis Intracranial Hemorrhages Cerebral Hemorrhage Antithrombin III Azetidines Perioperative Care Factor VII Pyrazoles Antibodies, Anticardiolipin Aryl Hydrocarbon Hydroxylases Risk Factors Time Factors Recurrence Rodent Control Randomized Controlled Trials as Topic Fibrin Fibrinogen Degradation Products Dose-Response Relationship, Drug Prospective Studies Heparin Antagonists Drug Substitution Hirudins Follow-Up Studies Pharmacovigilance Factor V Drug Therapy, Combination beta 2-Glycoprotein I

No FAQ available that match "oral anticoagulant anticoagulant warfarin"